ライフサイエンスコーパス: clinicopathological

1 ic extramedullary hematopoiesis, and altered clinicopathological abnormalities during mammalian colon

2 Parkinson's disease is not fully understood, clinicopathological analyses have led to the development

3 We integrated genomic and clinicopathological analyses of a cohort of patients wit

4 Furthermore, results from clinicopathological analysis revealed that elevated Cdh1

5 Upon clinicopathological analysis, the presence of natural CO

6 or the expression of SALL4 and carried out a clinicopathological analysis.

7 Hairy cell leukemia (HCL) shows unique clinicopathological and biological features.

8 Here, by correlating clinicopathological and expression data, we demonstrate

9 angliogliomas We evaluated the difference in clinicopathological and genetic features among 45 high-g

10 ily more possible to tailor treatment to the clinicopathological and immunogenetic profile of the ind

11 Clinicopathological and laboratory parameters were colle

12 We studied the clinicopathological and molecular characteristics of six

13 s of the lung (SQCLCs) are defined by unique clinicopathological and molecular characteristics that h

14 ays in the tumorigenesis of ACC, we examined clinicopathological and molecular data and used mouse mo

15 g these novel subgroups along with secondary clinicopathological and molecular features and establish

16 model and investigated for associations with clinicopathological and molecular features including age

17 We investigated the clinicopathological and molecular features of 85 resecte

18 These subgroups have distinct clinicopathological and molecular features, and underpin

19 ethylation and CIMP+ tumors have distinctive clinicopathological and molecular features.

20 Collectively, the clinicopathological and molecular findings point to a ca

21 The clinicopathological and molecular heterogeneity of endom

22 se (vCJD) is a unique and highly distinctive clinicopathological and molecular phenotype of human pri

23 Based on a review of recent clinicopathological and molecular studies, we propose a

24 (CDC2, CDC42) and expression correlated with clinicopathological and molecular variables and patient

25 Clinicopathological and outcome data were reviewed, and

26 We used multivariate analyses to evaluate clinicopathological and perioperative factors for associ

27 her these polymorphisms were associated with clinicopathological and phenotypic characteristics and w

28 enrichment of genetic pathways, and distinct clinicopathological and survival features.

29 r cells in blood provides a potential useful clinicopathological assay.

30 These results were further confirmed by a clinicopathological assessment in vivo.

31 es a novel contribution to understanding the clinicopathological associations in HD.

32 Certain relatively specific clinicopathological associations were identified.

33 Clinicopathological characterisation and shared haplotyp

34 hemotherapy, and was associated with patient clinicopathological characterisitcs.

35 pecimens and was statistically analyzed with clinicopathological characteristics and patients' surviv

36 genotypes with breast cancer susceptibility, clinicopathological characteristics and prognosis.

37 The clinicopathological characteristics associated with a SC

38 Clinicopathological characteristics of BRAF-mutated CM h

39 Clinicopathological characteristics of MECs was demonstr

40 Program and performed analysis to determine clinicopathological characteristics of PBS and estimate

41 Our study demonstrated clinicopathological characteristics of PBS in the US pop

42 tion of these genes was correlated with some clinicopathological characteristics of the patients.

43 wait period may be required depending on the clinicopathological characteristics of the previous SCC

44 tic features have been identified beyond the clinicopathological characteristics of the primary tumor

45 The relationship between PDW and clinicopathological characteristics were analyzed.

46 The relationships between MPV and clinicopathological characteristics were analyzed.

47 riate linear regression models adjusting for clinicopathological characteristics were used to analyze

48 progression-free survival, overall survival, clinicopathological characteristics, and pertuzumab trea

49 Demographics, clinicopathological characteristics, distribution of the

50 After controlling for clinicopathological characteristics, higher BMI was sign

51 Clinicopathological characteristics, perioperative detai

52 On the basis of conventional clinicopathological characteristics, physicians recommen

53 The primary outcome measures were clinicopathological characteristics, usefulness of EVD w

54 Measures: The primary outcome measures were clinicopathological characteristics, usefulness of EVD w

55 , and aim to ascertain the relationship with clinicopathological characteristics.

56 human HCC tissue microarray and analysis of clinicopathological characteristics.

57 the presence of the BRAF mutation and other clinicopathological characteristics.

58 ssed, nor has its relationship to presenting clinicopathological characteristics.

59 at baseline with respect to demographic and clinicopathological characteristics.

60 08) were assessed by genomic analysis and by clinicopathological characterization in specific-pathoge

61 present the complete genome sequence and the clinicopathological characterization of a virulent Newca

62 A large body of clinicopathological, circumstantial, and epidemiological

63 NG, PARTICIPANTS, AND EXPOSURE: Longitudinal clinicopathological cohort study at residences of partic

64 ergence of new fibril conformers with varied clinicopathological consequences.

65 neurodegenerative disease and the nuances of clinicopathological considerations.

66 ting Center autopsy cohort across the entire clinicopathological continuum of AD.

67 ctor for CTE pathological features, although clinicopathological correlates and the nature of onset a

68 cally by noninvasive imaging, the details of clinicopathological correlates have not been described.

69 of the epidemiologic factors, mechanism, and clinicopathological correlates of CTE reflect the curren

70 We investigated the spectrum and clinicopathological correlates of liver pathology in a h

71 plasmic inclusions play an important role in clinicopathological correlates of MSA.

72 at multiple levels and therefore traditional clinicopathological correlation approaches to better cla

73 A clinicopathological correlation between observed retinal

74 Clinicopathological correlation showed that sequestratio

75 A clinicopathological correlation was performed on 90 cons

76 Disease Center Brain Bank with near-optimal clinicopathological correlation.

77 ogies for MA via histological evaluation and clinicopathological correlation.

78 terized clinical cohorts in order to develop clinicopathological correlations at the synapse level.

79 We report clinicopathological correlations from 79 autopsy cases d

80 improve pathological prediction by exploring clinicopathological correlations in a large bvFTD cohort

81 Clinicopathological correlations in FTLD are subsequentl

82 Clinicopathological correlations with measures of verbal

83 icenter research on treatment interventions, clinicopathological correlations, and studies of cogniti

84 To investigate the spectrum of clinicopathological correlations, we performed a semi-qu

85 tonomously generated K6 antibodies alter the clinicopathological course of disease in murine proteoli

86 tion site of CC) independent of other common clinicopathological covariates.

87 Based on unique clinicopathological criteria, the most common immune inf

88 t to predict based on established prognostic clinicopathological criteria.

89 of public resources including brain samples, clinicopathological data and correlative gene expression

90 by immunohistochemistry and correlated with clinicopathological data and patient outcome using stand

91 ed to a retrospective review of computerized clinicopathological data and slides.

92 Diagnostic clinicopathological data from 10,139 men with non-metast

93 ile for anomalous mitral arcade, we compared clinicopathological data from 11 sets of autopsied twin-

94 Epidemiologic and clinicopathological data from current literature provide

95 b and NonOb groups were comparable regarding clinicopathological data, except for arterial hypertensi

96 w plasma cells, with long-term follow-up and clinicopathological data.

97 d correlated with overall survival and other clinicopathological data.

98 umour, with long-term follow-up and complete clinicopathological data.

99 cancer and to evaluate its association with clinicopathological data.

100 ow CERAD/intermediate Braak scores, that is, clinicopathological descriptors of early Alzheimer's dis

101 We detected a lower rate of clinicopathological discrepancy in critically ill patien

102 EE is a clinicopathological disease characterized by (1) Symptom

103 differences in PrP(Sc) might account for the clinicopathological diversity evident in Creutzfeldt-Jak

104 ssociated AIH have been proposed as distinct clinicopathological entities.

105 that corticobasal degeneration is a discrete clinicopathological entity but with a broader clinical s

106 pulmonary neuroendocrine cells (IDHPNC) is a clinicopathological entity characterized by a diffuse hy

107 ur findings (i) help to dissect one separate clinicopathological entity from what is likely to be a s

108 The definition of the clinicopathological entity of amyotrophic lateral sclero

109 We describe four cases of a new clinicopathological entity presenting with either a fron

110 associated MCD may be considered as a single clinicopathological entity regardless of HIV status.

111 tion of donor-specific antibodies (DSA) is a clinicopathological entity that carries a poor prognosis

112 arch in dementia because they delineated the clinicopathological entity that is now known as Alzheime

113 or body cavity-based lymphoma is a distinct clinicopathological entity that, in the majority of case

114 ersary of Alzheimer's lecture describing the clinicopathological entity which bears his eponym, this

115 Hairy cell leukemia (HCL) is a distinct clinicopathological entity whose underlying genetic lesi

116 t of vertical saccades represents a distinct clinicopathological entity.

117 ant qualifying statements outlining relevant clinicopathological factors and details of the reference

118 Clinicopathological factors and long-term survival were

119 Clinicopathological factors and overall outcome was anal

120 Clinicopathological factors and patient outcomes were me

121 Multivariate analysis including clinicopathological factors as covariates revealed high

122 f patient survival in association with other clinicopathological factors in univariate [hazard ratio

123 efficacy end points adjusted for prognostic clinicopathological factors including PIK3CA genotype.

124 In general, clinicopathological factors known to predict and drive a

125 The influence of clinicopathological factors on local recurrence, distant

126 nal lymph nodes (HR 3.2 95% CI 1.2-8.2) were clinicopathological factors predictive of decreased surv

127 ion between p16 alterations and conventional clinicopathological factors was noted in this cohort.

128 34; 95% CI, 2.53-34.48) after adjustment for clinicopathological factors, and the genetic duet showed

129 The stages were compared with clinicopathological factors, including seizure history a

130 ve upon prognostic information from existing clinicopathological factors, the potential of these nove

131 role of NLR after stratification by several clinicopathological factors.

132 ntries, and is influenced by patient age and clinicopathological factors.

133 etastatic disease, with due consideration of clinicopathological factors.

134 6; 95% CI, 2.97-116.18) after adjustment for clinicopathological factors.

135 in the portal veins (venous metastases) is a clinicopathological feature of metastatic HCCs.

136 of COX-2 expression in comparison with other clinicopathological features (age and tumor grade) and o

137 Clinicopathological features (eg, atypia, necrosis, and

138 luation of quantitative ERG1 expression with clinicopathological features also suggested that ERG1 ex

139 CXCR6 in prostate cancer (PC) was related to clinicopathological features and activation of inflammat

140 BRAF mutation status was compared with clinicopathological features and other genetic alteratio

141 tion between preoperative serum VEGF levels, clinicopathological features and patient survival, and t

142 There were more correlations between clinicopathological features and the loss of heterozygos

143 Participant clinicopathological features are more consistent with co

144 There were no significant differences in clinicopathological features at initial diagnosis and at

145 c loss of each xenografted cancer with known clinicopathological features for each patient and found

146 ight therefore contribute to the distinctive clinicopathological features in GISTs with different mut

147 n stromal genomic alterations and presenting clinicopathological features in sporadic breast cancer.

148 rosing cholangitis, a syndrome with distinct clinicopathological features including steroid responsiv

149 In addition, new insights into key clinicopathological features including symptoms such as

150 ese microenvironmental alterations relate to clinicopathological features is unknown.

151 We present the clinicopathological features of 20 Mexican children with

152 itical roles in the disease by linking other clinicopathological features of Alzheimer's disease.

153 oid-beta species respectively correlate with clinicopathological features of Alzheimer's disease.

154 btaining an overview of the epidemiology and clinicopathological features of BCC in the very elderly

155 of S100 in different intrinsic subtypes and clinicopathological features of breast cancer.

156 focused on identifying genes associated with clinicopathological features of HCC patients.

157 whose expression pattern is associated with clinicopathological features of HCC tumors.

158 tus auratus) with L. donovani reproduced the clinicopathological features of human VL, and investigat

159 urpose of this study was to characterize the clinicopathological features of invasive carcinomas aris

160 This study aims to characterize clinicopathological features of large flat colonic polyp

161 define the risk factors for progression, the clinicopathological features of PD, and the outcomes for

162 We also compared the clinicopathological features of the oral SCC cases with

163 regulators were assessed and correlated with clinicopathological features of the patients.

164 We present the clinicopathological features of two siblings from a cons

165 ementia (HAD), a neurological condition with clinicopathological features similar to Alzheimer's dise

166 ement has been challenged because these show clinicopathological features that are similar to branch

167 erns of pancreatic adenocarcinomas and their clinicopathological features were also determined.

168 Finally, clinicopathological features were analyzed against PTEN

169 between PD-L1 protein expression, TILs, and clinicopathological features were determined.

170 erythematous patches and has shown to share clinicopathological features with rectal prolapse, proct

171 isease has been limited by the heterogeneous clinicopathological features, difficulty in creating ani

172 h the stroma and epithelium, with presenting clinicopathological features, such as tumor grade, expre

173 expressed in the subgroups with "aggressive" clinicopathological features, was associated with an ele

174 splaying a somewhat unusual constellation of clinicopathological features, which overall subserve to

175 ively correlated with tumor stages and other clinicopathological features.

176 and found strong correlations with relevant clinicopathological features.

177 dvanced disease at baseline and more adverse clinicopathological features.

178 elapse risk scores based on their respective clinicopathological features.

179 the BRAF mutation was also compared with the clinicopathological features.

180 with recurrence-free survival, or with other clinicopathological features.

181 18q loss status was not associated with any clinicopathological features.

182 an tumors revealed several associations with clinicopathological features.

183 of cytokeratin 19 expression was related to clinicopathological features.

184 (PTFL) is a B-cell lymphoma with distinctive clinicopathological features.

185 of follicular lymphoma (FL) with distinctive clinicopathological features.

186 ral therapy and cotrimoxazole was a frequent clinicopathological finding; Mycobacterium tuberculosis

187 e purpose of this study was to correlate the clinicopathological findings and viral antigen distribut

188 With regard to skin blistering, the clinicopathological findings expand the molecular basis

189 f the MDR1 promoter and its correlation with clinicopathological findings were evaluated in 177 prost

190 followed an unusual course and had uncommon clinicopathological findings.

191 bladder cancers and correlated the data with clinicopathological findings.

192 matosis is now a complex entity with various clinicopathological forms based on mutations in the HFE

193 xpression in 286 invasive breast tumors with clinicopathological, hypoxia markers and survival.

194 Muc-ICCs had a clinicopathological, immunohistochemical, and molecular

195 To determine the clinicopathological implications of retinoblastoma (RB)

196 mparing their mRNA profiles with established clinicopathological indicators and mRNA profiles of estr

197 Clinicopathological information and follow-up data were

198 446 MBCs on tissue microarrays and assessed clinicopathological information, together with data from

199 Early clinicopathological investigations highlighted a number

200 these data were tested for associations with clinicopathological markers, disease-free survival, and

201 ted fibroblasts (CAFs) and assessed links to clinicopathological markers, prognostic and treatment-pr

202 higher area under the curve compared with a clinicopathological model (0.90 [95% CI 0.78-0.96] vs 0.

203 ved by addition of baseline CTC count to the clinicopathological models (progression-free survival LR

204 value of CTCs or serum markers to prognostic clinicopathological models in a resampling procedure usi

205 ntrally reviewed Ki67 significantly improves clinicopathological models to determine distant recurren

206 en use its output for survival analysis with clinicopathological multivariable adjustment in 7 indepe

207 Emerging evidence from epidemiological, clinicopathological, neuroimaging, biomarker, and experi

208 however no other significant differences in clinicopathological or molecular features were apparent.

209 This is likely to specifically reflect the clinicopathological overlap of ALS with frontotemporal d

210 Clinicopathological papers on several forms of non-HFE h

211 rcinomas were subcategorized on the basis of clinicopathological parameters (tumor primary site, hist

212 Data were correlated with clinicopathological parameters and patient outcomes.

213 han currently used postoperatively available clinicopathological parameters and potentially could be

214 resent, tumor grade and size are the primary clinicopathological parameters commonly used to guide de

215 HER2 status was confronted with clinicopathological parameters in order to assess statis

216 Clinicopathological parameters included LN status (N0/N1

217 tive index, as assessed by Ki-67, as well as clinicopathological parameters of poor outcome.

218 th the pRb and p53 pathways, correlated with clinicopathological parameters of worse prognosis.

219 h of tumor infiltration alone but additional clinicopathological parameters should also be considered

220 Similarly, patients differ in their clinicopathological parameters, but how genotypic and ph

221 y assignment with and without adjustment for clinicopathological parameters, including centrally revi

222 isk can be further stratified by a number of clinicopathological parameters.

223 atterns of multiple miRNAs combined with the clinicopathological parameters.

224 rived from the smoker patients and with poor clinicopathological parameters.

225 In this case, we present a novel clinicopathological pattern of AL amyloidosis.

226 ifferentiation facilitates prediction of the clinicopathological phenotype and duration of the diseas

227 The clinicopathological phenotype of the Gerstmann-Straussle

228 Human prion diseases, although variable in clinicopathological phenotype, generally present as neur

229 rther insight into the generation of diverse clinicopathological phenotypes associated with inherited

230 lar mechanism for generation of the multiple clinicopathological phenotypes seen in inherited prion d

231 tle is known on the link between strains and clinicopathological phenotypes, we studied potential str

232 metastatic breast cancer when added to full clinicopathological predictive models, whereas serum tum

233 ewed our experience with the aim to identify clinicopathological predictors of disease recurrence.

234 ts suggest that Richardson syndrome can be a clinicopathological presentation of corticobasal degener

235 Although clinicopathological presentations of GC are known to var

236 ed independent prognostic information to the clinicopathological prognostic factors.

237 pse risk scores to refine prognosis with the clinicopathological prognostic model alone.

238 ription-PCR assay that correlates with known clinicopathological prognostic parameters may have poten

239 multivariate analysis including established clinicopathological prognostic variables (HRRav, 0.67; P

240 cases (three splice-site mutations); in the clinicopathological referral series that used more gener

241 To date only a small number of anecdotal clinicopathological relations have been reported; neuroi

242 try, however, suggests that these concordant clinicopathological relationships are not universal and

243 We investigated the clinicopathological relevance of SPAG5 gene copy number

244 The underlying signalling pathways, of major clinicopathological relevance, are unknown.

245 ity of JAK inhibition to induce molecular or clinicopathological responses in MPNs suggests a need fo

246 tic factor in patients who otherwise had few clinicopathological risk factors; therefore, the CD68 sc

247 ic gland polyps (FGPs) occur in two distinct clinicopathological scenarios: sporadic and familial ade

248 SP was higher than most previous prospective clinicopathological series and studies using the retrosp

249 Large clinicopathological series have been published that have

250 screening of novel molecules in a simulated clinicopathological setting.

251 However, the clinicopathological significance and prognostic value of

252 In short, our data provided clinicopathological significance for STIM1 and SOCE in C

253 analyses on 125 primary tumours to evaluate clinicopathological significance of molecular subgroup a

254 The aim of this study was to investigate the clinicopathological significance of these molecular subt

255 ole of Pin1 in human PCa progression and its clinicopathological significance.

256 The clinicopathological similarities between lichen sclerosu

257 (TSG) and to correlate these losses with the clinicopathological stage of the disease.

258 ee of 74 colon cancer patients were of known clinicopathological stage.

259 and OCT4 levels positively correlated to the clinicopathological stages of HCC patients.

260 Clinicopathological studies are important in determining

261 We suggest that additional clinicopathological studies be performed in patients wit

262 h dementia live in developing countries, few clinicopathological studies focus on these individuals.

263 Recent clinicopathological studies have now also demonstrated t

264 Clinicopathological studies in four HIV-infected patient

265 white matter hyperintensities, we performed clinicopathological studies in post-stroke survivors, wh

266 Clinicopathological studies indicate that expression of

267 Clinicopathological studies of patients diagnosed as hav

268 We present a clinicopathological study and the first molecular geneti

269 us Orders Study, a prospective, longitudinal clinicopathological study of aging and Alzheimer's disea

270 oject (mean age, 88.0 years), a longitudinal clinicopathological study.

271 from a large, longitudinal, epidemiological clinicopathological study.

272 tient mortality was also observed in several clinicopathological subcategories, but statistical signi

273 Two clinicopathological subtypes are recognized: type I (end

274 support the hypothesis that AD has distinct clinicopathological subtypes.

275 MSA has been divided into two clinicopathological subtypes: MSA with predominant parki

276 ile neurofibrillary tangle formation and the clinicopathological syndrome of MND may occur in paralle

277 eases rather than classification by specific clinicopathological syndrome.

278 om Minnesota, MN; (2) a referral series with clinicopathological tauopathy; and (3) a pathologically

279 etween EBV infection and HP infection or any clinicopathological variable was detected.

280 on of POLE proofreading domain mutation with clinicopathological variables and immune response in col

281 Adjusting for clinicopathological variables and treatment arms, ERBB2/

282 d with breast cancer pathogenesis or several clinicopathological variables including receptor status

283 The clinicopathological variables of 59 patients resected fo

284 olecular markers tested were correlated with clinicopathological variables of the cohort, including t

285 les that reported the influence of 1 or more clinicopathological variables on overall survival after

286 Clinicopathological variables used at present for progno

287 Fifteen clinicopathological variables were analyzed to evaluate

288 arcinomas (Ta, n = 28; T1, n = 31) for which clinicopathological variables were available.

289 Clinicopathological variables, including TNM stage, hist

290 ct on survival, and were not associated with clinicopathological variables, patients with exon9 charg

291 fications was independent of tissue-specific clinicopathological variables, the proliferation marker

292 arkers to predict recurrence beyond standard clinicopathological variables, we calculated the change

293 perioperative data, including morbidity and clinicopathological variables, were analyzed.

294 stigate the predictive value of preoperative clinicopathological variables, with a special focus on a

295 ned CTC biomarker expression with respect to clinicopathological variables.

296 COX-2 and HER2 expression/amplification and clinicopathological variables.

297 as well as its association with HER2/neu and clinicopathological variables.

298 d validation cohorts independent of standard clinicopathological variables.

299 s with CRCLM with added value to established clinicopathological variables.

300 We describe correlative clinicopathological/virological findings from a simian v